HDC-23675-32884
2 vaccinations
4 coded responses
18 check-ins
0 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 431 / OH
- Registered
- 2023-03-04
- Relationship
- Child or adolescent in my care
- Guardian
- XC8-59611-49497
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2023-02-28
Dose 1 — Pfizer-BioNTech
-
2023-03-04
Registered in v-safe
-
2023-03-04
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Redness, Swelling/hardness · NoneUnder 3 check-in
-
2023-03-05
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Swelling/hardness · NoneUnder 3 check-in
- 2023-03-06
- 2023-03-07
- 2023-03-14
-
2023-03-21
Dose 2 — Pfizer-BioNTech
- 2023-03-22
- 2023-03-23
- 2023-03-24
- 2023-03-25
- 2023-03-26
- 2023-03-27
-
2023-03-28
Health check-in — day 7, dose 2, under 3Feeling: Fair · Vomiting · Be unable to work or attend schoolUnder 3 check-in
-
2023-04-04
Survey response — day 14, dose 2, under 3MedDRA: Pyrexia — Feeling: Poor · Be unable to work or attend schoolMedDRA releases: 2024-11
-
2023-04-11
Survey response — day 21, dose 2, under 3MedDRA: Ear infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-11
Report sent to call center — day 21, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-04-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-19
-
2023-04-25
Survey response — day 35, dose 2, under 3MedDRA: Cough, Nasopharyngitis — Feeling: FairMedDRA releases: 2024-11
-
2023-05-02
Survey response — day 42, dose 2, under 3MedDRA: Adverse drug reaction, Otitis media — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-05-02
Report sent to call center — day 42, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-05-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-06-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2023-02-28 | Pfizer-BioNTech | No |
| 2 | 2023-03-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-11 | Successful 2023-04-12 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-05-02 | Successful 2023-05-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse drug reaction | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Otitis media | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release